Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Skp2, the FoxO1 hunter.

Elinor Dehan1, Michele Pagano

  • 1Department of Pathology and NYU Cancer Institute, New York University School of Medicine, 550 First Avenue, MSB 599, New York, New York 10016, USA.

Cancer Cell
|March 16, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pan-cancer proteogenomic interrogation of the Ubiquitin Proteasome System.

bioRxiv : the preprint server for biology·2026
Same author

The E3-ome gene-centric compendium reveals the human E3 ligase landscape.

Cell·2026
Same author

GMCL1 controls 53BP1 stability and modulates taxane sensitivity.

eLife·2026
Same author

ZC3H4 safeguards genome integrity by preventing transcription-replication conflicts at noncoding RNA loci.

Science advances·2025
Same author

Nucleoporins cooperate with Polycomb silencers to promote transcriptional repression and repair at DNA double-strand breaks.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Stabilization of GTSE1 by cyclin D1-CDK4/6-mediated phosphorylation promotes cell proliferation with implications for cancer prognosis.

eLife·2025
Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
See all related articles

Skp2 oncoprotein promotes cell proliferation by degrading cell cycle regulators. New research shows Skp2 targets FoxO1, a tumor suppressor, suggesting a novel mechanism in cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Skp2 (S-phase kinase-associated protein 2) is an oncoprotein.
  • Skp2 promotes cell proliferation by degrading negative cell cycle regulators.

Purpose of the Study:

  • To investigate the role of Skp2 in the degradation of FoxO1.
  • To elucidate a novel mechanism by which Skp2 may contribute to tumorigenesis.

Main Methods:

  • Ubiquitylation assays
  • Protein degradation studies
  • Analysis of transcription factor function

Main Results:

  • Skp2 directs the ubiquitylation and degradation of FoxO1.
  • FoxO1 is a member of the FoxO family of transcription factors.

Related Experiment Videos

  • FoxO proteins exhibit tumor suppressor functions.

    • Conclusions:

    • Skp2-mediated degradation of FoxO1 represents a new mechanism promoting tumorigenesis.
    • Targeting Skp2 could be a potential strategy for cancer therapy.